Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Renate Wingefeld has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12762007

6-(4-HYDROXY-PHENYL)-3-ALKYL-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
C07D 471/04, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Renate Wingefeld, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12775026

6-(4-HYDROXY-PHENYL)-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
A61K 31/4745, A61K 31/4748, A61P 9/00, A61P 25/00, A61P 35/00, C07D 471/04, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Renate Wingefeld, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13723442

SUBSTITUTED 6-(4-HYDROXY-PHENYL)-1H-PYRAZOLO[3,4-B]PYRIDINE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 3/10, A61P 9/00, A61P 25/00, A61P 29/00, A61P 35/00, C07D 471/04
Applicant:
Sanofi, S.A.
Agent:
Renate Wingefeld, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature